Diaceutics PLC
DIUXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 22.44 | 0.15 | 3.79 | 1.54 |
| FCF Yield | -4.31% | -3.91% | 0.36% | -6.01% |
| EV / EBITDA | 29.07 | 31.35 | 16.46 | 31.06 |
| Quality | ||||
| ROIC | -5.34% | -5.13% | 1.12% | 1.40% |
| Gross Margin | 87.91% | 83.15% | 71.97% | 75.78% |
| Cash Conversion Ratio | -0.34 | -0.75 | 7.11 | 1.02 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.14% | 19.34% | 15.39% | 1.23% |
| Free Cash Flow Growth | -12.33% | -1,374.82% | 105.53% | 16.72% |
| Safety | ||||
| Net Debt / EBITDA | -4.21 | -6.44 | -5.13 | -8.58 |
| Interest Coverage | -45.46 | -45.73 | 2.71 | 3.56 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 55.56 | 58.60 | 144.46 | -55.45 |